Xynomic Pharmaceuticals, Inc. is a US incorporated biopharmaceutical company founded by US-China industry veterans and successful entrepreneurs. Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies.
Xynomic Pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in China, US and rest of the world. Xynomic Pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner.
Xynomic Pharma is headquartered in the Shanghai with major operations in US and Shanghai, China.
Company Details
- Employees
- 13
- Founded
- 2016
- Address
- 3500 South Dupont Highway,
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- xynomicpharma.com
- HQ
- Dover, DE
Xynomic Pharma Questions
Xynomic Pharma's website is xynomicpharma.com
Xynomic Pharma's LinkedIn profile is https://www.linkedin.com/company/xynomic-pharma
Xynomic Pharma has
13 employees.
View email and phone details for 13
employees at Xynomic Pharma.
Xynomic Pharma's industry is
Pharmaceutical Manufacturing
Xynomic Pharma's support email address is info@xynomicpharma.com
Xynomic Pharma's categories are Pharmaceutical Manufacturing
Xynomic Pharma's founding year is 2016
